UHC Medical Policy Updates

November 2019 ~

UnitedHealthcare (UHC) has released its latest medical policy updates, including medical policy, medical benefit drug policy & coverage determination guideline updates.

Medical Policy Updates

Policy: Articular Cartilage Defect Repairs

Effective: January 1, 2020

Update: Revised

Policy: Computed Tomographic Colonography

Effective: January 1, 2020

Update: Revised

Policy: Electrical Stimulation for the Treatment of Pain and Muscle Rehabilitation

Effective: January 1, 2020

Update: Revised

Policy: Genetic Testing for Hereditary Cancer

Effective: December 1, 2019

Update: Revised

Policy: Skin and Soft Tissue Substitutes

Effective: January 1, 2020

Update: Revised

Policy: Vagus and External Trigeminal Nerve Stimulation

Effective: December 1, 2019

Update: Revised

Policy: Visual Information Processing Evaluation and Orthoptic and Vision Therapy

Effective: December 1, 2019

Update: Revised

Medical Benefit Drug Policy Updates

Policy: Implementation Delayed for Medical Benefit Drug Policy Updates Effective:

Update: Updated

Policy: Botulinum Toxins A and B

Effective: December 1, 2019

Update: Revised

Policy: Clotting Factors, Coagulant Blood Products & Other Hemostatics

Effective: November 1, 2019

Update: Revised

Policy: Erythropoiesis-Stimulating Agents

Effective: January 1, 2020

Update: Revised

Coverage Determination Guideline (CDG) Updates

Policy: Breast Reduction Surgery

Effective: November 1, 2019

Update: Updated

Policy: Preventive Care Services

Effective: December 1, 2019

Update: Revised

Utilization Review Guideline (URG) Updates

Policy: Magnetic Resonance Imaging (MRI) and Computed Tomography (CT) Scan – Site of Service

Effective: November 1, 2019

Update: Updated

Policy: Outpatient Surgical Procedures – Site of Service

Effective: November 1, 2019

Update: Revised

The complete details on these updates can be viewed, here.

Source(s): November 2019 Network Bulletin;

 

 

AdvantEdge